Title | Genome-wide screen for Mycobacterium tuberculosis genes that regulate host immunity. |
Publication Type | Journal Article |
Year of Publication | 2010 |
Authors | Beaulieu AM, Rath P, Imhof M, Siddall ME, Roberts J, Schnappinger D, Nathan CF |
Journal | PLoS One |
Volume | 5 |
Issue | 12 |
Pagination | e15120 |
Date Published | 2010 Dec 10 |
ISSN | 1932-6203 |
Keywords | Animals, DNA Transposable Elements, Female, Gene Expression Regulation, Bacterial, Genes, Bacterial, Genome, Bacterial, Interleukin-12 Subunit p40, Interleukin-6, Macrophages, Mice, Mice, Inbred C57BL, Microscopy, Fluorescence, Mutation, Mycobacterium tuberculosis, Tumor Necrosis Factor-alpha |
Abstract | In spite of its highly immunogenic properties, Mycobacterium tuberculosis (Mtb) establishes persistent infection in otherwise healthy individuals, making it one of the most widespread and deadly human pathogens. Mtb's prolonged survival may reflect production of microbial factors that prevent even more vigorous immunity (quantitative effect) or that divert the immune response to a non-sterilizing mode (qualitative effect). Disruption of Mtb genes has produced a list of several dozen candidate immunomodulatory factors. Here we used robotic fluorescence microscopy to screen 10,100 loss-of-function transposon mutants of Mtb for their impact on the expression of promoter-reporter constructs for 12 host immune response genes in a mouse macrophage cell line. The screen identified 364 candidate immunoregulatory genes. To illustrate the utility of the candidate list, we confirmed the impact of 35 Mtb mutant strains on expression of endogenous immune response genes in primary macrophages. Detailed analysis focused on a strain of Mtb in which a transposon disrupts Rv0431, a gene encoding a conserved protein of unknown function. This mutant elicited much more macrophage TNFα, IL-12p40 and IL-6 in vitro than wild type Mtb, and was attenuated in the mouse. The mutant list provides a platform for exploring the immunobiology of tuberculosis, for example, by combining immunoregulatory mutations in a candidate vaccine strain. |
DOI | 10.1371/journal.pone.0015120 |
Alternate Journal | PLoS One |
PubMed ID | 21170273 |
PubMed Central ID | PMC3000826 |
Grant List | T32 AI007621 / AI / NIAID NIH HHS / United States T32 AI07621 / AI / NIAID NIH HHS / United States |
Submitted by jom4013 on December 3, 2020 - 3:45pm